Gambardella Valentina - Ferdinando De Vita, Alessio Fabozzi, Maria Maddalena Laterza, Jole Ventriglia, Beatrice Savastano, Angelica Petrillo, Valentina Gambardella, Vincenzo Sforza, Fortunato Ciardiello, Michele Orditura, Division of Medical Oncology, Department of Clinical and Experimental Medicine and Surgery, Second University of Naples School of Medicine, 80131 Naples, Italy.

基本信息

浏览量：24

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 96 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

27P Proteomic profiling reveals organ-specific differences in metastases and identifies potential biomarkers for recurrence risk in localized colon cancer

B. García-Micó,F. Gimeno-Valiente, J. Martin-Arana, B. Martínez-Castedo, M. García-Bartolomé, V. Seguí,V. Gambardella,D. Roda Perez,A. Cervantes, N. Tarazona Llavero

ESMO Openno. 1 (2023): 101673-101673

引用0浏览0引用

Genomic analysis of circulating tumor DNA (ctDNA) from patients with HR+, HER2-mutant metastatic breast cancer (MBC) enrolled in SUMMIT: mechanisms of acquired resistance to neratinib plus fulvestrant plus trastuzumab (N plus F plus T)

Cynthia Ma,James Waisman,Adam M. Brufsky,Eddy S. Yang,Hans Wildiers,John P. Crown,Sarina A. Piha-Paul,Jennifer M. Suga,Jose Angel Garcia-Saenz,Valentina Gambardella,Angel Guerrero,Salomon Stemmer,

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Initial results from a first-in-human, phase I study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964 in patients with advanced solid tumors

Ecaterina Elena Dumbrava,Michael Cecchini,Jon Zugazagoitia,Juanita Suzanne Lopez,Dirk Jager,Marc Oliva,Sebastian Ochsenreither,Valentina Gambardella, Ki Y. Chung, Federico Longo,Albiruni Ryan Abdul Razak,Martin Wermke,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 2502-2502

引用0浏览0引用

A phase 1/2 study of CFT1946, a novel, bifunctional degradation activating compound (BIDAC) degrader, of mutant BRAF V600 as monotherapy and in combination with trametinib, in mutant BRAF V600 solid tumors

Meredith McKean, Alexander I. Spira, Ezra Rosen,Vivek Subbiah,Victor Moreno,Valentina Gambardella,Maria Vieito, Omar Saavedra,Sophie Cousin,Philippe Alexandre Cassier,Riadh Lobbardi, Oliver Schonboern-Kellenberger,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): TPS3163-TPS3163

引用0浏览0引用

Abstract PD17-01: Genomic analysis of circulating tumor DNA (ctDNA) from patients with HR+, HER2-mutant metastatic breast cancer (MBC) enrolled in SUMMIT: mechanisms of acquired resistance to neratinib + fulvestrant + trastuzumab (N+F+T)

Cynthia Ma,James Waisman,Adam M. Brufsky,Eddy S. Yang,Hans Wildiers,John P. Crown,Sarina A. Piha-Paul,Jennifer M. Suga,José Ángel García-Sáenz,Valentina Gambardella,Angel Guerrero,Salomon Stemmer,

Cancer Researchno. 5_Supplement (2023): PD17-01

引用0浏览0引用

“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”

Federica Papaccio,Blanca García-Mico,Francisco Gimeno-Valiente,Manuel Cabeza-Segura,Valentina Gambardella,María Fernanda Gutiérrez-Bravo,Clara Alfaro-Cervelló,Carolina Martinez-Ciarpaglini,Pilar Rentero-Garrido,Sheila Zúñiga-Trejos,Juan Antonio Carbonell-Asins,Tania Fleitas,

J Exp Clin Cancer Res（2023）

引用7浏览0WOS引用

A phase I/Ib study of inavolisib (GDC-0077) in combination with fulvestrant in patients (pts) with PIK3CA-mutated hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer

Dejan Juric,Phillippe L. Bedard,Andres Cervantes,Valentina Gambardella,Mafalda Oliveira,Cristina Saura,Kevin M. Kalinsky,Erika Hamilton,Antoine Italiano,Ian E. Krop,Peter Schmid,Nicholas C. Turner,

CANCER RESEARCH（2022）

引用2浏览0引用

In the literature: February 2022

V Gambardella,J M Cejalvo, I González-Barrallo, F Gimeno-Valiente,A Cervantes

ESMO open（2022）

引用0浏览0WOS引用

Abstract P5-17-05: A phase I/Ib study of inavolisib (GDC-0077) in combination with fulvestrant in patients (pts) with PIK3CA-mutated hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer

Dejan Juric,Phillippe L Bedard,Andrés Cervantes,Valentina Gambardella,Mafalda Oliveira,Cristina Saura,Kevin M Kalinsky,Erika Hamilton,Antoine Italiano,Ian E Krop,Peter Schmid,Nicholas C Turner,

Cancer Research (2022)

引用2浏览0引用

64P Integrative immune transcriptomic classification could improve patient selection for precision immunotherapy in advanced gastroesophageal adenocarcinoma

M. Cabeza Segura,V. Gambardella, F. Gimeno-Valiente,J.A. Carbonell-Asins, L. Alarcon-Molero,A. Gonzalez-Vilanova, S. Zuniga-Trejos,P. Rentero-Garrido, R. Villagrasa,M. Gil Raga, P. Richart,M. Huerta,

Annals of Oncologyno. 8 (2022): S1402-S1403

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn